Results

Total Results: 1,474 records

Showing results for "indicated".

141. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - We present summaries on three topics (indicated below by an asterisk) that emerged as having high-impact … Ivacaftor tablets are indicated for oral administration, one 150 mg dose every 12 hours for patients … also being evaluated in 10 other CFTR gene mutations known to cause CF, which could expand the indicated … ivacaftor’s price is considered to be the highest-cost drug therapy on the market today, the company indicated … One report indicated that hospitals in Europe pay about $60,000 for each machine.60 Clinical Pathway

142. Updating Current Effectiveness Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
     September 15, 2008 - Using this approach, they determined that out of 17 guidelines, new evidence and expert assessment indicated … Survival analysis indicated that about half the guidelines were outdated in 5.8 years; at 3.6 years,

143. Disposition of Comments Report for Comparative Effectiveness Review No. 131 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
     February 25, 2014 - Please note in the review that CZP is not indicated for the induction of remission of Crohn’s disease … We considered all drugs for induction and maintenance, regardless of how they are indicated. … For those treatments that are not indicated for Crohn’s disease, the recommended doses evaluated in … Infliximab does have the following FDA indications in pediatric patients: INFLIXIMAB is indicated for … As indicated above, we revised the summary of key findings and added a section offering a clinical

144. Disposition of Comments Report for Otitis Media With Effusion (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
     May 04, 2013 - We have indicated that we could not find studies focused on subgroups (page ES-20, Research Gaps): … We limited our discussion to tympanoscentesis, pneumatic otoscopy, and hearing loss; we also indicated … The strength of evidence table in the results section indicated that there were mixed findings for … We have indicated in the research gaps the methodological limitations of many studies. … We have further indicated that use of a common outcome protocol would facilitate pooling results.

145. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
     April 06, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: April 06, 2010 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness and Safety of Oral Diabetes Medications for Adu…

146. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
     May 19, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: May 19, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update I. Background and Objectives for the Sys…

147. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
     January 01, 2013 - Considerations Define exposure (treatments) of interest at start of followup Use an active comparator (indicated

148. S108 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s108.pdf
     October 01, 2007 - Values less than 1 indicated bias away from the null, values of 1 indicated an absence of bias, and values … greater than 1 indicated bias toward the null.42 In this simulation, confounding produced unadjusted

149. uterine-fibroids-protocol-160301 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
     March 01, 2016 - uterine-fibroids-protocol-160301   Source: www.effectivehealthcare.ahrq.gov Published online: March 1, 2016 Evidence-based Practice Center Systematic Review Protocol Project Title: Management of Uter ine Fibroids I. Background and Objectives for the Systematic Review Topic background Most women will dev…

150. Evidence Summary for Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-evidence-summary.pdf
     December 01, 2020 - Low back pain (38 trials): Evidence indicated that there might be no difference between an opioid versus

151. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
     March 01, 2011 - medical patients Dalteparin sodium (Fragmin ® ) Subcutaneous 5,000 IU QD Eisai/Pfizer 1994 Indicated … sodium (Innohep ® ) Subcutaneous 3,500 IU QD to 4500 IU SC daily LEO Pharma/Celgene 2000 Indicated … Xa Inhibitors Fondaparinux (Arixtra ® ) Subcutaneous 2.5 mg QD GSK 2001 Indicated … , 2012 prophylaxis Rivaroxaban (Xarelto ® ) Oral 10 mg QD Johnson and Johnson 2011 Indicated

152. Tympanostomy Tubes in Children With Otitis Media (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-executive-170523.pdf
     May 01, 2017 - The number of studies that include each comparison is indicated next to each edge (connecting lines with … The number of studies that include each comparison is indicated next to each edge (connecting lines with … The number of studies that include each comparison is indicated next to each edge (connecting lines … At baseline, the generic and disease-specific health-related quality-of-life scores indicated good quality

153. Disposition of Comments_Technical Brief No. 48_Use of Life Cycle Assessment in the Healthcare Industry: Environmental Impacts and Emissions Associated With Products, Processes and Waste (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-disposition-comments.pdf
     November 20, 2024 - Manufacturer data in this space The figure has been revised to reflect the type of data sources indicated … KI Reviewer #2 Findings [pg. 21, GQ3b, "Over half of the studies indicated further LCA studies were … (just curious) The majority of the studies that indicated further studies were needed were published … Peer reviewer #2 Findings On page 22, the first bullet point mentions that key informants indicated

154. Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
     December 01, 2012 - three of the GEP assays: ColoPrint® Colon Cancer Recurrence Assay and the OncoDefender-CRC assay, indicated … available within 7 to 10 days following receipt of the tumor sample and Oncotype DX® Colon Cancer assay indicated … If so, the predictive assay would be used if the prognostic result indicated high risk of recurrence … Input from Key Informants indicated that currently there is little use of GEP assays in the clinical … Input from Key Informants indicated that current standard of care for stage II patients does not include

155. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
     January 01, 2024 - Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update Comparative Effectiveness Review Number 250 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update Exec…

156. Executive Summary_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforces (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-executive-summary.pdf
     February 01, 2025 - Executive Summary_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforces Systematic Review M ental Health and Occupational Stress in the Emergency Medical Services and 911 Workforces Executive Summary Main Points • No study reported o…

157. S13 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
     October 01, 2007 - ORIGINAL ARTICLE Methodologic Challenges to Studying Patient Safety and Comparative Effectiveness Brian L. Strom MD, MPH Abstract: Studies of patient safety and comparative effectiveness entail unique methodologic challenges. These studies may be sus- ceptible to systematic error, including selection bias, exposure …

158. Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-usability-testing.pdf
     November 01, 2018 - Interviewees liked the key messages and indicated that these should be on the first page. … Interviewees indicated that the colors of the products were appealing; however, summaries should also … No change, as participants indicated they liked the white space that the combination of images and … One non- researcher indicated that although the page did not resonate very well with them, they could … Number of studies and participants contributing to each meta- analysis is indicated.

159. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - We present five summaries on topics (indicated below by an asterisk) that emerged as having higher-impact … Reports in Europe have indicated that insulin degludec has cost 60% to 70% more than competitors on … Reports from Europe have indicated that insulin degludec costs 60% to 70% more than competitors on … In February 2011, the Lap-Band received approval for the labeling change, which indicated its use for … The FDA has indicated that Alimera will need to conduct two additional clinical trials to demonstrate

160. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
     August 22, 2008 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: January 22, 2010 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Effectiveness of Recombinant Human Growth Hormone in the Treatment of Cystic Fibrosis…